Objectives: Dyshomeostasis of the dopaminergic system is implicated in the pathophysiology of eating disorders (EDs). We have previously reported an association between 3'-UTR VNTR (three prime untranslated region variable number of tandem repeat) of the Dopamine Transporter 1 (DAT1) gene and ED with binge eating behavior (EDBEB). Here we investigated whether variants in the coding region of the DAT1 gene also associate with EDBEB. Methods: The coding region and exon-intron junctions of the DAT1 gene were screened by direct sequencing using genomic DNA from EDBEB patients (n = 90) and healthy subjects (n = 114) on whom 3'-UTR VNTR variants had been previously determined. Results: rs2270912 and rs28363130, two of five known polymorphisms found by this screen, were significantly associated with EDBEB patients by genotype (p = 0.003, p = 0.011, respectively) and allele (p = 0.003, p = 0.012, respectively) frequency compared with healthy subjects. Interestingly, these polymorphisms associate with the risk 3'-UTR VNTR variant of EDBEB. Conclusion: Although our sample size was small, we show here that rs2270912 and rs28363130 associates with EDBEB and might act with 3'-UTR VNTR as a haplotype. These findings support the notion that the DAT1 gene plays a key role in the dopaminergic system of EDBEB.
Introduction
Eating disorders (EDs) are psychiatric disorders that include abnormal eating behaviors, such as refusing to eat (restrictive eating) and overeating (binge eating) or excretory behaviors to prevent weight gain by vomiting food or using laxatives and diuretics, which often develop among young women who are between the stages of late puberty and early adulthood [1] [2] . In particular, ED with binge eating behavior (EDBEB) are often accompanied by abnormal eating behavior and alcohol or drug dependence [3] [4] , mood swings such as depression and being easily upset, or character changes [1] , which lead to impulsive behaviors such as shoplifting, sexual promiscuity [5] , self-mutilation, or attempting suicide [6] .
The development of EDs has been indicated to be affected by not only a psychosocial sense of value, such as extreme obsession with weight, e.g., being skinny means being beautiful, but also genetic factors [7] . Therefore, the development of ED and its disease state is currently considered to be associated with psychosocial factors that are closely related to genetic factors [8] , which is similar to mental disorders such as bipolar disorder and schizophrenia. To elucidate the development of ED and its disease state, clinical genetic studies such as twin studies [9] , family studies [10] , and various genome-wide association studies (GWASs) are being conducted; however, no consensus on the results regarding candidate genes for ED has been reached [7] [11] [12] .
The dopamine system greatly affects emotions, substance dependence, and eating behaviors [13] [14] . Abnormalities in the dopamine system have been indicated in the pathophysiology of ED [14] . A gene that plays an important role in the dopamine system is the solute carrier family 6 member 3 (SLC6A3, Gene ID: 6531), alternatively known as DAT (dopamine transporter) or DAT1 (hereinafter, DAT1 is used). The DAT1 gene encodes a transmembrane protein that regulates dopamine reuptake from synapses and possesses variable number of tandem repeats (VNTRs) in its 3'-untranslated region (3'-UTR) [15] . Polymorphisms in the number of repeats influence DAT1 gene expression [16] . Besides ED [17] , the associations of polymorphisms with attention-deficient/hyperactivity disorder [18] , alcohol [19] , smoking [20] , and cocaine dependence [21] , and schizophrenia [22] are known.
From our group, Shinohara et al. previously reported the association between EDBEB and 3'-UTR VNTRs in the DAT1 gene by comparing seven or nine VNTR short alleles with 10 or 11 VNTR long alleles [23] . However, no study has assessed the association between EDBEB and regions other than the 3'-UTR VNTRs in the DAT1 gene. Therefore, in this study, we conducted a genetic polymorphism analysis by focusing on the coding region of the DAT1 gene using a previously studied Japanese sample set and closely reinvestigated the association 
Subjects and Methods

Subjects
In this study, we employed the sample sets previously used by Shinohara et al. [23] to assess the association between EDBEB and polymorphisms in the 3'-UTR VNTRs in the DAT1 gene. However, among the healthy subject group, the genomic DNA of one patient was depleted. The total number of subjects in the patient group with EDBEB was 90 (Japanese females: mean 22.1 ± SD (standard deviation) 4.0 years) and that in the healthy subject group was 114 (Japanese females: mean 18.7 ± SD 1.1 years). Diagnostic assessment and characteristics of the subjects are as previously reported [23] [24] . Patients with EDBEB were required to satisfy the diagnostic criteria described in the Diagnosis and Statistical
Manual of Mental Disorders, 4 th Edition [25] , have a history of visiting a hospital that specialized in treating patients with ED for >3 years, and have no changes in the diagnosis over a 3-year period. In addition, symptoms were evaluated according to the Eating Disorder Inventory [26] . The healthy subject group included individuals whose weights were maintained with fluctuations within 20% of the standard body weight. Furthermore, after obtaining the approval of the Ethics Committee of the University of Yamanashi, this study was conducted with individuals who provided informed consent after receiving written and oral explanations before initiating the study. Moreover, the study was anonymized by giving each sample a number to prevent the identification of individuals and protect private information.
Extraction of Genomic DNA
Genomic DNA was extracted from the peripheral blood of test subjects using a
QIAamp DNA Blood Kit (Qiagen, Tokyo, Japan). Genomic DNA was stored frozen at −20˚C until the tests mentioned below were conducted.
Polymerase Chain Reaction
Intron-exon information of the DAT1 gene was confirmed from the DAT1 mRNA sequence (SLC6A3: NM_001044) and DAT1 gene sequence (NG_015885).
Using this information, exons (from exon 2 to 14) that corresponded to the coding region of the DAT1 gene were amplified by polymerase chain reaction (PCR) using the genomic DNA of each test subject as a template. Each primer was designed using the nucleotide sequence of the DAT1 gene as a reference, with primers homologous to the upstream and downstream intron sequences bordering each exon ( Table 1 ). The nucleotide sequences of both exon 2 and 4 are long; therefore, each exon was split into overlapping fragments and then amplified using each specific primer pair (Table 1) . PCR was performed using the PCR System 9700 (Thermo Fisher Scientific Inc., Waltham, MA, USA), and conditions for each PCR cycle are shown in Table 2 . PCR products were Open Journal of Psychiatry 
Nucleotide Sequencing Analysis of Polymerase Chain Reaction Products
To investigate mutations in the DAT1 gene, the nucleotide sequence of each PCR product was analyzed by direct sequencing. PCR products were electrophoresed using 2% agarose gel containing ethidium bromide, and each PCR product with the predicted length was observed under UV light. Each PCR product was extracted from gels using a Microcon centrifugal filter (EMD Millipore Corp., Billerica, MA, USA) and purified. The nucleotide sequence of each purified PCR product was determined by direct sequencing using an ABI 377S
DNA sequencer (PerkinElmer Japan Co., Ltd., Kanagawa, Japan).
Statistical Analysis
Hardy-Weinberg equilibrium analysis (HWE) of each obtained genotype and an association study of the patient group with the healthy subject group were conducted using SNPAlyze Ver.8.0.1 Standard (DYNACOM, Chiba, Japan). However, some identified polymorphisms were not analyzed according to the Hardy-Weinberg equilibrium; therefore, the Cochran-Armitage trend test was performed for the association study. Statistical power was evaluated using single nucleotide polymorphism (SNP) tools (http://www.bioinformatics.org/snp-tools-excel) [27] . P values of <0.05 were considered to be statistically different. Because of the small sample size, an association study of identified polymorphisms with the 3'-UTR VNTR was performed only for haplotype frequency.
Results
Genetic Polymorphism Analysis of the DAT1 Gene
Exons 2-14 of the DAT1 gene were amplified by PCR using genomic DNA from each test sample (total of 204 samples: 90 samples from the patient group and 114 samples from the healthy subject group) as the template and using primers designed such that each primer was homologous to the upstream and downstream intron sequences that bordered each exon. The nucleotide sequence of each sequence was then analyzed by direct sequencing. Five polymorphisms, namely rs460000 (C → A) located in intron 3, rs6347 (A → G) located in exon 9, rs2270912 (C → T) located in exon 10, rs429699 (G → A) located in intron 11, and rs28363130 (A → G) located in intron 13, were identified; however, all these polymorphisms were already registered in GenBank® (https://www.ncbi.nlm.nih.gov/genbank/). Furthermore, rs6347 and rs2270912
were polymorphisms that did not cause amino acid substitutions, although they were located in exons ( Figure 1 and Table 3 ). Open Journal of Psychiatry The position of each identified polymorphism was relative to the first nucleotide of exon 1 of the DAT1 gene (NG_015885).
Genotype Frequency and Hardy-Weinberg Equilibrium
The possible genotypes of rs460000 (C → A) were C/C, C/A, and A/A, with the number of test samples in each genotype being 25 (27.8%), 48 (53.3%), and 17 (18.95%), respectively, in the patient group and 27 (23.7%), 60 (52.6%), and 27 (23.7%), respectively, in the healthy subject group. HWE showed a p value of 0.530 in the patient group and a p value of 0.708 in the healthy subject group; thus, no significant differences were observed in either group, and they agreed with the HWE. However, it showed significant differences in the healthy subject group (p = 0.027), and the values did not agree with the HWE.
The possible genotypes of rs2270912 (C → T) were C/C, C/T, and T/T, with the number of test samples in each genotype being 83 (92.2%), 7 (7.8%), and 0 (0%), respectively, in the patient group and 114 (100%), 0 (0%), and 0 (0%), respectively, in the healthy subject group. No samples with T/T were present in both the groups, and no samples with C/T were present in the healthy subject group; therefore, the HWE analysis was not performed. (0%), respectively, in the patient group and 113 (99.1%), 1 (0.9%), and 0 (0%) in the healthy subject group. As no samples with G/G were present in either group, the HWE analysis was not performed. Furthermore, genotype frequency and HWE of each genotype in the patient and healthy subject groups are shown in Table 4 .
Association Study by the Cochran-Armitage Trend Test
The allelic frequency of each C and A allele of rs460000 was 54.4% (98 alleles) and 45.6% (82 alleles), respectively, in the patient group and 50.0% (114 alleles) and 50.0% (114 alleles), respectively, in the healthy subject group. Thus, no significant difference was observed in the allelic frequency between the two groups (p = 0.357).
The allelic frequency of each A and G allele of rs6347 was 87.2% (157 alleles) and 12.8% (23 alleles), respectively, in the patient group and 91.7% (209 alleles) and 19% (83 alleles), respectively, in the healthy subject group. Thus, no significant difference was observed in the allelic frequency between the two groups (p = 0.151).
The allelic frequency of each C and T allele of rs2270912 was 96.1% (173 alleles) and 3.9% (7 alleles), respectively, in the patient group and 100% (228 alleles) and 0% (0 allele), respectively, in the healthy subject group. Therefore, a significant difference was observed in the allelic frequency between the two Open Journal of Psychiatry Table 4 .
Haplotype Analysis
The associations of EDBEB with rs2270912, rs28363130, and 3'-UTR VNTR were investigated using haplotype analysis. However, the sample number was small, and homozygous rs2270912 T alleles, homozygous rs28363130 G alleles, and homozygous short 3'-UTR VNTRs were not found in our sample sets. Therefore, haplotype frequencies alone were reported. Genetically, 27 haplotypes could be present; however, only six haplotypes were confirmed in the study. Among these haplotypes, the haplotype C/C-A/A-Long/Long (rs2270912-rs28363130-3'-UTR VNTR) was found to have the highest frequency in the patient group (76.7%: 69/90 samples) and the healthy subject group (91.2%: 104/114 samples) ( Table 5 ).
All seven patient samples with the rs2270912 T allele, which was not found in the healthy subject group, possessed the short 3'-UTR VNTR, which is a risk allele for developing EDBEB. Furthermore, six of eight patient samples with the rs28363130 G allele had the short 3'-UTR VNTR; moreover, these six samples possessed the rs2270912 T allele (C/T-A/G-Long/Short; 6.7%: 6/90 samples) ( Table 5 ).
Discussion
An association study of the DAT1 gene with EDBEB was conducted using 204 genomic DNA samples obtained from 90 patients with EDBEB and 114 healthy subjects among Japanese females. All five polymorphisms found in the DAT1 gene in this study were already known. However, among these five polymorphisms, rs2270912 and rs28363130 showed a significant association with EDBEB. A significant association of rs6347 with EDBEB regarding the genotype frequency was found, although no significant association was found regarding Table 5 . Haplotype frequencies of the DAT1 gene in the EDBEB patient and healthy subject groups (rs2270912-rs28363130-3'-UTR VNTR). The polymorphism rs2270912 (C → T) located in exon 10 is a silent mutation, which does not cause amino acid substitution. Silent mutations in the exon that are known as protein function, which is encoded by a gene containing a silent mutation, would not be affected because no amino acid substitution occurs. An increasing body of evidence revealed that silent mutations may have the ability to change in its encoded protein expression and structure [28] . ST8SIA2 (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2, Gene ID: 8128, alternatively known as STX) that synthesizes polysialic acid involved in synaptic plasticity, the development of normal neural circuits and neurogenesis [29] , is a susceptibility gene for schizophrenia, bipolar disorder, and autism spectrum disorder [30] . A functional genetic analysis of silent SNP (C → G), which is located in exon 5 of the STX gene, revealed that the enzymatic activity of STX protein decreased in the overexpressing mutant STX gene compared with that in the overexpressing wild-type STX gene in CHO cells [31] . From these reports, rs2270912, a polymorphism with a silent mutation, may alter the DAT1 protein structure, function, or activity. EDBEB was found, it was discovered that six of seven patients with EDBEB who had the rs2270912 T allele also possessed the rs28363130 G allele and the short 3'-UTR VNTR allele (haplotype: C/T-A/G-Long/Short; 6.7%: 6/90 patients). In our sample sets, this haplotype was not present in the healthy subject group.
Unfortunately, MAFs of rs2270912 and rs28363130 were extremely low, being 0.00367 and 0.00230, respectively. Moreover, a homozygote of each rs2270912 T allele, rs28363130 G allele, and short 3'-UTR VNTR was not present in our sample sets. Therefore, statistical analysis was not performed, and haplotype frequencies alone are presented in Table 5 . This haplotype analysis revealed a possible association of the haplotype created by the T allele at rs2270912, the G allele at rs28363130, and short 3'-UTR VNTR with the susceptibility to patients with EDBEB.
Regarding 3'-UTR VNTR, there is a report that DAT1 expression is decreased in the striatum in the subject group with short 3'-UTR VNTR-440, where nine tandem repeats were observed in the 3'-UTR VNTR [34] , whereas there are reports indicating an increase in DAT1 expression [35] and no change in DAT1 expression [36] ; thus, there is no consensus regarding DAT1 expression and short 3'-UTR VNTR-360. It has been reported that haplotypes, comprising mutations accompanied by a mutation with amino acid substitution and a silent mutation, can modify the expression and function of genes such as ACBC1
(ATP-binding cassette subfamily B member 1), commonly known as multidrug resistance protein 1, which encodes a P-glycoprotein involved in drug resistance [37] , and NKX2-5 (NK2 homeobox 5), which is involved in congenital heart diseases [38] . From these reports, there is the possibility that the function of the DAT1 gene can be modified by the haplotypes of 3'-UTR VNTR, rs2270912, and rs28363130. Moreover, it is believed that the molecular investigation of the hap- 
Conclusion
In our study, only the Japanese sample sets were used. Furthermore, the sample size was small (n = 204). Therefore, the statistical power for detection was low.
Moreover, optimum primer sets could not be constructed for analyzing the polymorphisms of exon 15; therefore, the entire exon of the coding region of the DAT1 gene could not be analyzed. Nonetheless, we were able to identify two polymorphisms that are believed to be associated with patients with EDBEB and indicate an association between these mutations and polymorphisms in 3'-UTR VNTR. To identify the DAT1 gene plays a key role in the dopaminergic system of EDBEB, it will be needed to conduct statistical haplotype analysis of rs2270912, rs28363130, and 3'-UTR VNTRs using a larger sample size and functional analysis of rs2270912, rs28363130, and 3'-UTR VNTRs by direct testing in future.
